;Pharmaceutical formulations include the organic compounds or pharmaceutically acceptable salts thereof and a pharmaceutically acceptable carrier can be prepared. Methods of preparing the compounds includes deprotecting protected precursor compounds. Methods of treating cancer or inhibiting ATPase include administering the organic compounds to a subject in need thereof."/>
公开/公告号US2008249162A1
专利类型
公开/公告日2008-10-09
原文格式PDF
申请/专利号US20080098001
申请日2008-04-04
分类号A61K31/335;C07D313;A61P35;
国家 US
入库时间 2022-08-21 20:11:53